NASDAQ:MBOT - Microbot Medical Stock Price, Forecast & News

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.

Microbot Medical Inc (NASDAQ:MBOT) posted its quarterly earnings data on Wednesday, November, 14th. The biotechnology company reported ($0.58) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.60) by $0.02. View Microbot Medical's Earnings History.

Microbot Medical is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Microbot Medical.

1 Wall Street analysts have issued 1 year price targets for Microbot Medical's stock. Their forecasts range from $26.00 to $26.00. On average, they anticipate Microbot Medical's share price to reach $26.00 in the next twelve months. This suggests a possible upside of 191.8% from the stock's current price. View Analyst Price Targets for Microbot Medical.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Microbot Medical.

Media headlines about MBOT stock have been trending somewhat positive on Monday, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Microbot Medical earned a media sentiment score of 1.8 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Microbot Medical.

Microbot Medical saw a increase in short interest in the month of January. As of January 15th, there was short interest totalling 430,700 shares, an increase of 202.2% from the December 31st total of 142,500 shares. Based on an average trading volume of 1,140,000 shares, the short-interest ratio is currently 0.4 days. Currently, 10.1% of the shares of the company are short sold. View Microbot Medical's Current Options Chain.

Some companies that are related to Microbot Medical include Verona Pharma (TARA), CASI Pharmaceuticals (CASI), ADMA Biologics (ADMA), Jounce Therapeutics (JNCE), LogicBio Therapeutics (LOGC), Windtree Therapeutics (WINT), Fennec Pharmaceuticals (FENC), Dyadic International (DYAI), Solid Biosciences (SLDB), Erytech Pharma (ERYP), Brainstorm Cell Therapeutics (BCLI), X4 Pharmaceuticals (XFOR), Gamida Cell (GMDA), Axcella Health (AXLA) and Cidara Therapeutics (CDTX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include TransEnterix (TRXC), Advanced Micro Devices (AMD), Novavax (NVAX), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Sarepta Therapeutics (SRPT), NovaBay Pharmaceuticals (NBY), Inovio Pharmaceuticals (INO) and Micron Technology (MU).

Microbot Medical's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (3.00%) and Virtu Financial LLC (0.95%). View Institutional Ownership Trends for Microbot Medical.

MBOT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Microbot Medical.

MBOT stock was acquired by a variety of institutional investors in the last quarter, including Virtu Financial LLC. View Insider Buying and Selling for Microbot Medical.

Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MBOT stock can currently be purchased for approximately $8.91.

Microbot Medical has a market capitalization of $55.95 million. The biotechnology company earns $-7,240,000.00 in net income (profit) each year or ($2.41) on an earnings per share basis. Microbot Medical employs 9 workers across the globe.View Additional Information About Microbot Medical.

The official website for Microbot Medical is http://www.microbotmedical.com/.

Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]